PubMed

Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.

Wang JY, Roehrl MH.

Med Immunol. 2005 Mar 24;4(1):4.PMID: 15790405 [PubMed - as supplied by publisher]Related articlesFree article

A dually active anthrax vaccine that confers protection against both bacilli and toxins.

Rhie GE, Roehrl MH, Mourez M, Collier RJ, Mekalanos JJ, Wang JY.

Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10925-30. Epub 2003 Sep 5.PMID: 12960361 [PubMed - indexed for MEDLINE]Related articlesFree article

Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.

Skoble J, Beaber JW, Gao Y, Lovchik JA, Sower LE, Liu W, Luckett W, Peterson JW, Calendar R, Portnoy DA, Lyons CR, Dubensky TW Jr.

Infect Immun. 2009 Apr;77(4):1649-63. Epub 2009 Jan 21.PMID: 19168734 [PubMed - indexed for MEDLINE]Related articlesFree article

Molecular basis for improved anthrax vaccines.

Brey RN.

Adv Drug Deliv Rev. 2005 Jun 17;57(9):1266-92. Epub 2005 Apr 21. Review.PMID: 15935874 [PubMed - indexed for MEDLINE]Related articles

Combining anthrax vaccine and therapy: a dominant-negative inhibitor of anthrax toxin is also a potent and safe immunogen for vaccines.

Aulinger BA, Roehrl MH, Mekalanos JJ, Collier RJ, Wang JY.

Infect Immun. 2005 Jun;73(6):3408-14.PMID: 15908368 [PubMed - indexed for MEDLINE]Related articlesFree article

Is new always better than old?: The development of human vaccines for anthrax.

Baillie LW.

Hum Vaccin. 2009 Dec;5(12):806-16. Epub 2009 Dec 9.PMID: 19786839 [PubMed - in process]Related articles

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

Infect Immun. 2009 Mar;77(3):1197-207. Epub 2008 Dec 29.PMID: 19114543 [PubMed - indexed for MEDLINE]Related articlesFree article

Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.

Bouzianas DG.

Expert Rev Anti Infect Ther. 2007 Aug;5(4):665-84. Review.PMID: 17678429 [PubMed - indexed for MEDLINE]Related articles

Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.

Enkhtuya J, Kawamoto K, Kobayashi Y, Uchida I, Rana N, Makino S.

Microbiology. 2006 Oct;152(Pt 10):3103-10.PMID: 17005989 [PubMed - indexed for MEDLINE]Related articlesFree article

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.PMID: 17646360 [PubMed - indexed for MEDLINE]Related articlesFree article

Intranasal administration of dry powder anthrax vaccine provides protection against lethal aerosol spore challenge.

Huang J, Mikszta JA, Ferriter MS, Jiang G, Harvey NG, Dyas B, Roy CJ, Ulrich RG, Sullivan VJ.

Hum Vaccin. 2007 May-Jun;3(3):90-3. Epub 2007 May 13.PMID: 17375001 [PubMed - indexed for MEDLINE]Related articles

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.PMID: 17502384 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG.

Infect Immun. 2005 Oct;73(10):6885-91.PMID: 16177368 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunization against anthrax using Bacillus subtilis spores expressing the anthrax protective antigen.

Duc le H, Hong HA, Atkins HS, Flick-Smith HC, Durrani Z, Rijpkema S, Titball RW, Cutting SM.

Vaccine. 2007 Jan 4;25(2):346-55. Epub 2006 Aug 4.PMID: 17007969 [PubMed - indexed for MEDLINE]Related articles

Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategy.

Baillie LW, Rodriguez AL, Moore S, Atkins HS, Feng C, Nataro JP, Pasetti MF.

Vaccine. 2008 Nov 11;26(48):6083-91. Epub 2008 Sep 19.PMID: 18805452 [PubMed - indexed for MEDLINE]Related articles

Detoxified lethal toxin as a potential mucosal vaccine against anthrax.

Xu Q, Zeng M.

Clin Vaccine Immunol. 2008 Apr;15(4):612-6. Epub 2008 Feb 6.PMID: 18256208 [PubMed - indexed for MEDLINE]Related articlesFree article

Anthrax protective antigen delivered by Salmonella enterica serovar Typhi Ty21a protects mice from a lethal anthrax spore challenge.

Osorio M, Wu Y, Singh S, Merkel TJ, Bhattacharyya S, Blake MS, Kopecko DJ.

Infect Immun. 2009 Apr;77(4):1475-82. Epub 2009 Jan 29.PMID: 19179420 [PubMed - indexed for MEDLINE]Related articlesFree article

Past, imminent and future human medical countermeasures for anthrax.

Baillie LW.

J Appl Microbiol. 2006 Sep;101(3):594-606. Review.PMID: 16907809 [PubMed - indexed for MEDLINE]Related articles

Oral administration of a Salmonella enterica-based vaccine expressing Bacillus anthracis protective antigen confers protection against aerosolized B. anthracis.

Stokes MG, Titball RW, Neeson BN, Galen JE, Walker NJ, Stagg AJ, Jenner DC, Thwaite JE, Nataro JP, Baillie LW, Atkins HS.

Infect Immun. 2007 Apr;75(4):1827-34. Epub 2006 Dec 4.PMID: 17145938 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.

Schneemann A, Manchester M.

Future Microbiol. 2009 Feb;4:35-43. Review.PMID: 19207098 [PubMed - indexed for MEDLINE]Related articlesFree article